Simultaneous targeting or multiple pathways of shock: how promising, how novel?
Szabó
C
C
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005544:Forecasting; D006801:Humans; D007249:Inflammation / Q000378:metabolism*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D012769:Shock / Q000188:drug therapy* / Q000378:metabolism*; D020032:Tyrphostins / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D016207:Cytokines; D004791:Enzyme Inhibitors; D020032:Tyrphostins; C069028:AG 127; D000242:Cyclic AMP; D011505:Protein-Tyrosine Kinases